BioCentury
ARTICLE | Clinical News

CINtec p16 Histology test regulatory update

September 15, 2014 7:00 AM UTC

Roche's Ventana Medical Systems Inc. unit said the World Health Organization (WHO) issued guidance recommending the use of cyclin dependent kinase inhibitor 2A ( CDKN2A; INK4a; ARF; p16INK4a) imm...